Skip to main content

Pancreatic Cancer Clinical Trials

Review the pancreatic cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 251-275 of 298

[18F]FTT Positron Emission Tomography/Computed Tomography for the Imaging of Pancreatic Neuroendocrine Tumors
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
PYLARIFY PET-CT for Detection of Metastasis in Pancreatic, Liver, or Breast Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
18F-FSPG PET in Imaging Patients with Liver Cancer before Undergoing Surgery, Transplant or Y90 Radioembolization
Status: Active
Location: 2 locations
An Investigational Scan (FAP-2286 PET) for the Imaging of Solid Tumors
Status: Active
Location: University of California San Francisco, San Francisco, California
New PET Scan (68Ga-FAPI-46) for People with Cancers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals with a High-Risk of Developing Pancreatic Cancer, AI-PACED Trial
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Diffusion Basis Spectrum Imaging for Assessing Microenvironment Tumor Effects in Patients with Cervical or Pancreatic Cancer Undergoing Radiation Therapy, METEOR-CRATR Trial
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Multiparametric Ultrasound for the Imaging of Cancerous and Non-cancerous Tissue in the Pancreas and Thyroid
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Intravital Microscopy in Human Solid Tumors
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Status: Active
Location: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Studying the Effects of Liver Size Changes for the Improvement of Stereotactic Body Radiation Therapy Planning and Delivery for Upper Abdominal Malignancies
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Genetic Education for BRCA Families
Status: Active
Location: 5 locations
A Visual Template for the Improvement of the Consent Process for Participants Enrolling in Clinical Trials (AHRQ Aim 3)
Status: Active
Location: 3 locations
A Support Program (BOLSTER) for the Improvement of Quality of Life in Metastatic Gynecologic or Gastrointestinal Cancer Patients with Complex Care Needs and their Caregivers, BOLSTER Trial
Status: Active
Location: 2 locations
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients with a Known Family History of Pancreatic Cancer
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
A Psychosocial Oncology Intervention During Neoadjuvant Therapy for Patients with Localized Pancreatic Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Association between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-Cancer Patients
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients with Cancer
Status: Active
Location: Virginia K Crosson Cancer Center, Fullerton, California
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Status: Active
Location: 2 locations
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Status: Active
Location: See ClinicalTrials.gov
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 727 locations
Biomarker Analysis in Improving Screening in Patients with or at High Risk of Developing Pancreatic Cancer
Status: Active
Location: 9 locations